Skip to content

TuHURA Biosciences, Inc. HURA Merger Transaction Costs Not Yet Paid

Merger Transaction Costs Not Yet Paid at other companies

Ceva logo
CevaCEVA
$0
CorMedix logo
CorMedixCRMD
$2.55M
SITE Centers Corporation logo
SITE Centers CorporationSITC
$0-100%
Installed Building Products logo
Installed Building ProductsIBP
$700K+75.0%
CS Disco logo
CS DiscoLAW
$0-100%
CTO
Citius Oncology, Inc.CTOR
$688.57K

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept hura:MergerTransactionCostsNotYetPaid.

The official record: TuHURA Biosciences, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s merger transaction costs not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s merger transaction costs not yet paid?
TuHURA Biosciences, Inc. (HURA) reported merger transaction costs not yet paid of $125K in Q4 2024.
What does merger transaction costs not yet paid mean?
Tracks the outstanding obligations for professional fees, legal expenses, and other costs associated with merger or acquisition activities that have not yet been settled in cash. It provides visibility into the remaining financial commitments required to finalize a business combination.